Siim Land: Biohacking Longevity, Health Span Truths & Cutting Through the Noise

#1

New Kaeberlein optispan with health span influencer Siim Land.

If you are a Kaeberlein groupie like me… I can’t get enough of his full honesty and critical review of unsubstantiated claims and misinformation.

Matt K. and P. Attia podcasts deep dives on aging and rapamycin got me started on rapamycin.

8 Likes
#2

I recommend this podcast. I was just going to post this episode, In the start of the show he makes some very good points about not taking medical advice from Bryan Johnson. What do people think about this talk? Did I hear Growth Hormone, DHEA and Metformin? Interesting

1 Like
#4

Reached 21:49. Nothing substantial yet. Clicking out now.

4 Likes
#5

I don’t think it’s accurate to put undue weight that Bryan quit rapamycin because of the biological age paper. And it’s pretty simple to know if you get the common side effects from rapamycin. Your side effects improve after you quit it.

Sure we can’t know whether it was nocebo or placebo or something else because of N=1, but it’s not like most of these side effects haven’t been reported elsewhere and in the literature. I think it would be interesting to see if side effects are lower for those who get them at lower doses or different formulations.

Polypharmacy if they don’t affect e.g CYP3A4 might be additive, not suddently reverse to be negative, if we see what polygenic genomics can teach us, Kamil Pabis has written about this on his blog.

2 Likes
#6

So thankful Kaeberlein has Bryan Johnson to complain about now, not just the Harvard guy. Variety is the spice of life, Maslow 101.

Someone please develop an AI that can listen to a video, and generate an accurate transcipt - and not get the speakers mixed up.

Or maybe make a GLP-1, but for video consumption.

1 Like
#7

I’m so sorry, and apologize profusely ahead of time, but can someone do a bullet point list of value added health insights from the over an hour long interview blob?

While I value MK’s health related contributions, his own podcast I find severely undewhelming 90% of the time. It’s either pitched at the lowest common denominator viewer with 101 level standard nostrums, or the guests are pointless zero value influencers plus some dodgy kooks.

I actually listened to the full interviews of health knowledge non-entities with outsize subscription numbers, the deLaurers, Muntzls and other assorted yt cash grabbers, and found zero value. I can only speculate as to why he does it - perhaps he’s hoping to leach away some subscribers from these more popular guys… if so, it’s doomed to fail. A deLaurer subscriber is only going to be interested in 101 stuff - is this what MK is hoping to attract, giving up his own comparartive advantage and differentiating high level content? Regardless, this will backfire. It’ll discourage more serious listeners, and not result in success in competition with far more slick clickbait optimizers and supplement pill pushers like Mutzel. And yet, it’s possible to have modest success with deep dives into science - look at Simon Hill and his The Proof podcast - he has a fraction of MK’s qualifications, does a metric ton of deep dives and has a modest but growing sub count. MK, IMHO should rethink the orientation of his podcast, BWDIK.

As a result I’m reluctant to waste another hour+ on this Land guy. I’m aware of who he is, some years ago I watched one of his videos and it was clear to me that he’s just another no value added grifter infesting this space, hoping to rob you of your time to monetize clicks.

Frankly, I much prefer MK on other peoples podcasts to his own performance on his own podcast. Very sad, that I’m forced to have so little faith in his efforts in this area that I must rely on the kindness of others in giving me a heads up. TIA!

4 Likes
#8

Yeah tbh not an attention grabbing guest. Siim comes off too young and not willing to be out there with a strong opinion. Caspar Milquetoast.

I am probably too old… 67 years on Saturday. Ugh.

3 Likes
#9

Hey there, at least you made it in good shape… I myself am hitting 67 next month, also in reasonable shape - if I say so myself - judging by friends and acquaintances in the same age group. Glass half full.

1 Like
#10

congratulations. Have a nice day.

1 Like
#11

I agree with you that Siim is too young, I’m happy to see the younger folks taking an interest in longevity, but a young person might respond very different than someone much older than him. A strong opinion would be helpful.

2 Likes
#12

I also found too long and too superficial, learned nothing new.

I was wondering how to avoid wasting my time in the future
I tried copiing the youtube transcript in a txt file and asking ChatGPT to give me a summary. Works pretty well.

I also asked what the 3 main insigths were:

  1. Focus on healthspan over lifespan
  • The hosts argue that living longer is meaningless without good quality of life.
  • They encourage listeners to prioritize avoiding chronic disease, preserving metabolic flexibility, and maintaining strength and cognition into old age.
  • “Don’t chase immortality — chase functionality.”
  1. Basic lifestyle choices still outperform fancy interventions
  • The best interventions remain boring and obvious: exercise, sleep, whole food nutrition, and stress management.
  • Advanced supplements, extreme biohacks, or expensive protocols like Bryan Johnson’s “Blueprint” may have marginal gains, but the fundamentals matter more.
  • There’s skepticism around overreliance on tracking or quantified-self gadgets if people haven’t mastered basic habits.
  1. The science doesn’t support radical life extension yet
  • They criticize longevity escape velocity and the hype surrounding it.
  • No intervention has yet shown convincing evidence of lifespan extension in humans, especially not in healthy individuals.
  • They urge a measured, skeptical approach: track biomarkers, yes, but don’t get swept up in the Silicon Valley optimism.

I then asked for both parties position on Rapamycin
Matt Kaeberlein (host)

  • Critical of rapamycin skeptics, specifically naming Bryan Johnson as spreading misinformation.
  • Suggests that the data on rapamycin is often misrepresented, and he’s concerned about influential figures dismissing it without proper nuance.
  • Implies that while rapamycin is not a miracle drug, the scientific evidence behind it is stronger than what some critics claim​.

Siim Land (guest)

  • Doesn’t directly take a strong stance on rapamycin in the transcript, but agrees in general with Matt’s concern about overstated claims in the longevity world.
  • Emphasizes lifestyle over pharmacological interventions, implying that drugs like rapamycin might be overhyped if not guided by data and context.

Summary:

  • Kaeberlein defends rapamycin against unfair criticism and stresses its evidence base.
  • Siim Land seems cautious and reserved, aligning more with prioritizing lifestyle and careful interpretation of data.
6 Likes
#13

Thank you guys, you saved me an hour of low value waffling.

4 Likes
#14

Here’s a more succinct approach–and not one word about he who must not be named.

“It’s estimated that at least 80 percent of cardiovascular disease cases, 40 percent of cancer cases and 45 percent of Alzheimer’s cases are preventable.”

2 Likes
#15

Stanford Scientist: Why Aging Accelerates at 44 and 60

Nonlinear Aging and Phenotypic Tracking

I. Executive Summary

The provided transcript features a technical dialogue with Dr. Michael Snyder, Chair of Genetics at Stanford University, delineating the multi-omic architecture of human biological decline and personalized healthspan optimization. The central paradigm of the discussion is the validation of nonlinear molecular aging. Rather than progressing along a gradual, linear continuum, the human body undergoes two distinct, accelerated biological inflection points or “aging waves” occurring at the average ages of 44 and 60. Through deep, high-frequency, longitudinal profiling of transcripts, proteins, metabolites, lipids, and microbiome compositions over a 13-year period, the Snyder Lab demonstrated that roughly 81% of all profiled molecules exhibit dramatic, non-linear shifts at these specific chronological milestones. The mid-40s wave is heavily characterized by dysregulation in lipid, alcohol, and caffeine metabolism alongside structural muscle and skin alterations. Conversely, the early-60s wave triggers steep drop-offs in immune regulation, carbohydrate metabolism, and nephrotic/kidney function panels.

Beyond these universal aging waves, the transcript deconstructs the profound biological heterogeneity of aging via the “ageotype” framework, establishing that individuals deteriorate along distinct, predictable physiological vectors: metabolic, immune, hepatic, or nephrotic. This inter-individual variance is mirrored in early glucose dysregulation. Machine-learning algorithms analyzing continuous glucose monitoring (CGM) curve morphology during at-home oral glucose tolerance tests (OGTT) can now distinguish between distinct underlying metabolic subphenotypes, such as peripheral muscle insulin resistance versus pancreatic beta-cell insufficiency. Furthermore, the dialogue highlights a major paradigm shift in longevity genetics: recent mathematical modeling that isolates and removes historical extrinsic mortality (e.g., infections, accidents) reveals that the true heritability of intrinsic human lifespan is 50% to 55%, more than doubling traditional cross-sectional estimates.

To systematically counteract these biological drop-offs, the discussion bridges real-time tracking with advanced clinical interventions. Dr. Snyder proposes a tripartite theoretical blueprint for radical lifespan extension beyond the 120-year human barrier: autologous mitochondrial transplantation to replace organelles degraded by somatic mutations, targeted senolytic destruction of inflammatory senescent “zombie” cells, and continuous autologous pluripotent stem cell replenishment of failing organ niches. For immediate clinical execution, the protocol mandates continuous physiological monitoring using multi-sensor wearables and home-based dried-blood spot micro-sampling. These methods capture subtle longitudinal shifts away from an individual’s established personal baseline, allowing for automated, artificial intelligence-driven preventive course corrections months before the manifestation of clinical symptoms or irreversible organ damage.

II. Insight Bullets

  1. Nonlinear Molecular Aging (The 44/60 Waves): Longitudinal multi-omic profiling confirms that human aging is non-linear, marked by two massive lurches or accelerated biological “waves” centered around the average ages of 44 and 60 [Shen et al., 2024].
  2. Mid-40s Pathological Profile: The biological wave at age 44 is defined by rapid shifts in molecular pathways governing lipid regulation, alcohol clearance, and caffeine metabolism, matching clinical spikes in early cardiovascular presentation and musculoskeletal complaints [Shen et al., 2024].
  3. Early-60s Pathological Profile: The biological wave at age 60 triggers a synchronized, systemic drop-off in carbohydrate metabolism, adaptive immune response mechanisms, and renal filtration pathways [Shen et al., 2024].
  4. The Ageotype Framework: Human aging can be segmented into four distinct, predictable, and frequently overlapping biological pathways called ageotypes: metabolic, immune, hepatic, and nephrotic [Ahadi et al., 2020].
  5. Intrinsic Lifespan Heritability Revision: When mathematical models isolate and strip away extrinsic causes of death (accidents, acute infections), the true heritability of the intrinsic biological human lifespan rises to 50% to 55%, doubling historical estimates [Shenhar et al., 2026].
  6. Glucotype Subphenotyping via CGM: Prediabetic states exhibit distinct metabolic defects (e.g., muscle insulin resistance vs. pancreatic beta-cell dysfunction) that can be accurately mapped by machine-learning models assessing the morphology of a patient’s continuous glucose monitor curve [Snyder et al., 2025].
  7. Sarcopenia and Disuse Inflexibility: Skeletal muscle mass drops at roughly 2% per decade, but acute periods of complete muscular disuse or injury accelerate this wasting within 48 hours; after age 40, the physiological capacity to regain this lost mass is significantly blunted.
  8. GLP-1 Agonist Muscle Wasting Risks: Incretin mimetics (GLP-1 receptor agonists) like semaglutide or tirzepatide safely deplete visceral fat stores but pose a severe clinical risk of accelerating concurrent lean skeletal muscle wasting if unmitigated.
  9. Fiber-Driven Epigenetic Signaling: Ingested dietary fiber undergoes microbial fermentation into short-chain fatty acids (SCFAs), which act as active ligands directly targeting gene expression pathways essential for maintaining gut mucosal barrier integrity.
  10. The Physiological Shift Alert Gap: Multi-sensor consumer wearables can detect clear step-function anomalies (elevated resting heart rate, collapsed HRV, and altered gate/sleep architectures) up to four months prior to major cardiovascular failures; however, standard medical infrastructure lacks real-time infrastructure to act on these signals.
  11. Retinal Scans as Multi-System Biopsies: Artificial intelligence algorithms processing non-invasive 3D retinal scans can effectively predict future risks for neurodegenerative disease (Alzheimer’s), bone mineral density loss (osteoporosis), and advanced ischemic cardiovascular disease.
  12. Personal Baselines vs. Population Averages: Standard diagnostic reference ranges fail to identify early disease because they rely on population cross-sections; true predictive medicine requires tracking internal longitudinal deviations from an individual’s unique molecular baseline.
  13. High-Frequency Metabolomic Micro-sampling: Capillary blood micro-sampling allows patients to remotely mail in dried blood spots every 90 days to track 650 unique metabolites, offering real-time readouts of oxidative stress, inflammation, and visceral organ load.
  14. Absolute Lifespan Extension Key 1 (Mitochondrial Injections): Pushing human longevity past the historical 120-year barrier will require autologous mitochondrial transplantation to replace organelles degraded by somatic mitochondrial DNA mutations and electron transport chain leakages.
  15. Absolute Lifespan Extension Keys 2 & 3 (Senolytics & Stem Cells): Secondary and tertiary absolute longevity vectors require the systematic clear-out of senescent “zombie” cells via senolytic compounds and the active replenishment of somatic tissues with autologous, reprogrammed pluripotent stem cells.

IV. Actionable Protocol (Prioritized)

High Confidence Tier (Protocols backed by Level A/B evidence)

  • At-Home Glucotype Identification and Targeted Nutrition: Deploy a continuous glucose monitor (CGM) for a minimum of 14 to 30 days annually to establish your personal food-spiking profile (“glucotype”). Utilize strategic macronutrient sequencing by consuming a fiber-rich salad or protein block immediately prior to simple carbohydrates (e.g., french fries or white rice) to utilize fiber-mediated gastric slowing and blunt postprandial glucose excursions [Snyder et al., 2025].
  • Wearable-Based Personal Baseline Monitoring: Utilize a multi-sensor wearable device to map strict individual baselines for resting heart rate (RHR) and heart rate variability (HRV). Program automated alerts to flag systemic shifts away from personal baselines (e.g., a sudden 50% drop in HRV or a sustained increase in RHR), which serve as early diagnostic signals for acute viral infections (including COVID-19) or psychological stress before symptoms manifest.

Experimental Tier (Protocols backed by Level C/D evidence with high safety margins)

  • Subtype-Specific Pharmacotherapy for Dysglycemia: If presenting with lean-phenotype type 2 diabetes or a confirmed pancreatic beta-cell defect (sluggish insulin secretion rather than peripheral insulin resistance), bypass standard first-line metformin protocols under medical supervision. Instead, implement targeted therapies like GLP-1 receptor agonists or insulin secretagogues that directly correct the underlying cellular defect [Snyder et al., 2025].
  • Resistance Training Mitigation for GLP-1 and Age-Induced Sarcopenia: If undergoing incretin mimetic therapy (tirzepatide/semaglutide) or entering the post-44/60 aging waves, mandate daily or near-daily progressive resistance exercises. This is required to counteract the rapid 48-hour molecular disuse atrophy signaling pathway and preserve lean skeletal muscle mass.
  • High-Frequency Multi-Omic Micro-sampling: Implement quarterly capillary blood micro-sampling (dried-blood spot tracking) to screen a panel of 650+ metabolites. Track longitudinal trend lines in oxidative stress, renal clearance markers, and inflammatory cytokines to identify sub-clinical transitions toward your specific ageotype (metabolic, immune, hepatic, or nephrotic).

Red Flag Zone (Claims debunked or lacking safety data)

  • Passive Aging Assumption [DEBUNKED]: Relying on the outdated model that human biological decline is a slow, linear process that can be managed by late-stage lifestyle interventions. Failure to implement aggressive heart, metabolic, and muscle protection frameworks prior to the critical molecular inflection bursts at ages 44 and 60 results in accelerated, unmitigated tissue degradation [Shen et al., 2024].
  • Unregulated Commercial Stem Cell Transplants [HIGH RISK]: Procuring systemic or localized stem cell injections from unverified, commercial offshore clinics claiming generic rejuvenation. Clinical data regarding safety margins, pure cell lineage, and oncogenic risks remain highly controversial and lack rigorous human validation.
  • Over-the-Counter Direct-to-Consumer Mitochondrial Supplements [SAFETY DATA ABSENT]: Consuming unverified supplements that claim to clean or replace intracellular mitochondria. True organelle rejuvenation requires advanced autologous mitochondrial transfer or highly targeted clearance pathways that cannot be replicated via standard oral over-the-counter formulations.
1 Like
#16

This is an interesting question. There are potentially thresholds with a big shift in the recruitment of bromodomain proteins. That would create a distinctive shift in gene expression.

Additionally mitochondria can be improved on average through selective mitophagy.

1 Like
#17

First time I’m hearing about this " rapid 48-hour molecular disuse atrophy signaling pathway " suffered by people over 44. No even sure what it means, actually. Needs to be verified with paper or citation.

2 Likes
#18

The Rapid 48-Hour Molecular Disuse Atrophy Pathway

The Claim: Contractile inactivity triggers a rapid 48-hour molecular signaling cascade that initiates muscle atrophy.

The Evidence

  • Acute Phase Transcriptional Changes: Human immobilization models show that the molecular signaling pathways governing muscle degradation are activated within the very initial phase (2 to 4 days) of disuse (Suetta et al., 2012). Specifically, mRNA expression levels of muscle-specific E3 ubiquitin ligases—Atrogin-1 (MAFbx) and MuRF-1—spike rapidly to tag muscle structural proteins for proteasomal degradation, concurrent with a sharp collapse in mitochondrial transcriptional coactivators PGC-1α and PGC-1β (Suetta et al., 2012).
  • Immediate Loss of Mass: Human lower limb tracking confirms that disuse muscle atrophy occurs at its most aggressive, rapid rate during the initial 48 hours to first few days of sudden unloading or strict bed rest before hitting an eventual plateau (Hardy et al., 2022).
  • Structural Vulnerability: Within the first 48 hours of muscle unloading, contractile elements undergo sarcomeric disruption and Z-line streaming, leaving muscle fibers mechanically weakened and highly susceptible to cell membrane tearing and severe inflammatory infiltration upon reloading (Mirzoev, 2020).

Hardy, E. J. O., Inns, T. B., Hatt, J., Doleman, B., Bass, J. J., Atherton, P. J., Lund, J. N., & Phillips, B. E. (2022). The time course of disuse muscle atrophy of the lower limb in health and disease. Journal of Cachexia, Sarcopenia and Muscle, 13(5), 2616-2629. https://doi.org/10.1002/jcsm.13067 Cited by: 93

Jiang, B. C. (2025). The Benefits of Exercise Training in Combination With Weight Loss Therapies. PubMed Central (PMC), PMC12418233. The Benefits of Exercise Training in Combination With Weight Loss Therapies - PMC

Mesinovic, J. (2025). Exercise and dietary recommendations to preserve musculoskeletal health during weight loss in adults with obesity: A practical guide. PubMed Central (PMC), PMC12534310. Exercise and dietary recommendations to preserve musculoskeletal health during weight loss in adults with obesity: A practical guide - PMC Cited by: 11

Mirzoev, T. M. (2020). Skeletal Muscle Recovery from Disuse Atrophy: Protein Turnover Signaling and Strategies for Accelerating Muscle Regrowth. International Journal of Molecular Sciences, 21(21), 7940. https://doi.org/10.3390/ijms21217940 Cited by: 84

Murugadoss, K., Venkatakrishnan, A. J., & Soundararajan, V. (2026). Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotyping. medRxiv, 2026.04.11.26350687. Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotyping Cited by: 2

Shen, X., Wang, C., Zhou, X., Zhou, W., Hornburg, D., Wu, S., & Snyder, M. P. (2024). Nonlinear dynamics of multi-omics profiles during human aging. Nature Aging, 4(6), 1619–1634. https://cris.bgu.ac.il/en/publications/nonlinear-dynamics-of-multi-omics-profiles-during-human-aging-2/

Suetta, C., Frandsen, U., Jensen, L., Jensen, M. M., Jespersen, J. G., Hvid, L. G., Bayer, M., Petersson, S. J., Schrøder, H. D., Andersen, J. L., Heinemeier, K. M., Aagaard, P., Schjerling, P., & Kjaer, M. (2012). Aging Affects the Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy. PLoS ONE, 7(12), e51238. Aging Affects the Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy Cited by: 205

1 Like
#19

The studies above that refer to muscle disuse, talk bout complete immobilisation, which is different to me than taking a break/rest. This is fine to mention for people in hospital beds, but most of the population is not immobilized.

2 Likes
#20

But a lot of us are sitting at our desks all day looking at a computer (which may not be as far from “bed rest” as we’d like to think :wink:

1 Like
#21

Agree to disagree. Seems like a stretch to me, unless there are studies that show those disuse numbers after 8 hours immobilization

2 Likes